Duchenne Muscular Dystrophy clinical trials at UC Irvine
2 research studies open to eligible people
EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
open to eligible males ages 12-50
A study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON study was expanded to include an additional 120 adult participants in a cohort called GRAND CANYON, that is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of sevasemten in adults with Becker. CANYON is fully enrolled; GRAND CANYON is currently enrolling.
Orange, California and other locations
Defining Endpoints in Becker Muscular Dystrophy
open to eligible males ages 6 years and up
This is a 24-month, observational study of 50 participants with Becker muscular dystrophy (BMD)
Orange, California and other locations
Our lead scientists for Duchenne Muscular Dystrophy research studies include Tahseen Mozaffar, MD.
Last updated: